Suppr超能文献

一种新的包含新病理变量和交互项的前列腺癌根治术后列线图,可改善预后。

A post-radical-prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis.

机构信息

Tissugen Pty Ltd and School of Pathology and Laboratory Medicine, Uropath, Western Australia, Australia.

出版信息

BJU Int. 2011 Feb;107(3):389-95. doi: 10.1111/j.1464-410X.2010.09539.x. Epub 2010 Aug 12.

Abstract

OBJECTIVE

To evaluate new variables in prostate pathology reporting including, the per cent of Gleason patterns 4 and/or 5 (% 4/5), presence or absence of intraductal carcinoma of the prostate (IDCP), tumour volume and the prostatic zone of tumour origin as predictors of post-radical-prostatectomy (RP) biochemical recurrence (BCR). To develop an optimal postoperative nomogram for patients with prostate cancer.

PATIENTS AND METHODS

Our study cohort was 1939 eligible patients from the Abbott West Australian Prostatectomy Database. Multivariate Cox proportional hazard regression models were developed to predict BCR which was defined as prostate-specific antigen (PSA) ≥ 0.2 ng/mL. Our models and the 2009 Kattan postoperative nomogram were compared in terms of discrimination and calibration, with internal validation of our final model performed using bootstrapping methods. Our final model is presented as a nomogram.

RESULTS

The Kattan nomogram was accurate in discriminating our patients according to risk (concordance index: 0.791) but calibration analysis indicated underestimation of patient risk, particularly for high-risk disease. Our nomogram incorporates % 4/5, IDCP and prostate weight plus interaction terms between % 4/5, positive surgical margins and extracapsular extension, giving improved predictive accuracy (concordance index: 0.828) and calibration.

CONCLUSIONS

Nomograms that predict risk of BCR defined as PSA ≥ 0.4 ng/mL may not be optimal for patient cohorts where BCR is defined as PSA ≥ 0.2 ng/mL. If our findings are validated in other populations, current post-RP nomograms may be improved to a modest degree by incorporating the new variables prostate weight, IDCP and % 4/5, and by considering interactions between predictive variables.

摘要

目的

评估前列腺病理报告中的新变量,包括前列腺癌中格里森模式 4 和/或 5 的比例(% 4/5)、是否存在前列腺导管内癌(IDCP)、肿瘤体积和肿瘤起源的前列腺区作为预测前列腺癌根治术后(RP)生化复发(BCR)的指标。为前列腺癌患者开发最佳的术后列线图。

患者和方法

我们的研究队列是来自 Abbott 西澳大利亚前列腺切除术数据库的 1939 名合格患者。采用多变量 Cox 比例风险回归模型预测 BCR,定义为前列腺特异性抗原(PSA)≥0.2ng/mL。我们的模型和 2009 年 Kattan 术后列线图在区分度和校准度方面进行了比较,使用 bootstrap 方法对我们最终模型进行了内部验证。我们的最终模型以列线图的形式呈现。

结果

Kattan 列线图准确地根据风险对我们的患者进行了区分(一致性指数:0.791),但校准分析表明低估了患者的风险,特别是对于高危疾病。我们的列线图纳入了% 4/5、IDCP 和前列腺重量,以及% 4/5、阳性手术切缘和包膜外延伸之间的交互项,提高了预测准确性(一致性指数:0.828)和校准度。

结论

预测 PSA≥0.4ng/mL 定义的 BCR 风险的列线图可能不适用于 PSA≥0.2ng/mL 定义的 BCR 的患者队列。如果我们的研究结果在其他人群中得到验证,目前的 RP 术后列线图可以通过纳入新的变量,如前列腺重量、IDCP 和% 4/5,并考虑预测变量之间的交互作用,适度地得到改进。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验